Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07418723Not ApplicableCompleted

Personalised Process-based Psychological Interventions for Paediatric Headaches

Role: collaborator

NCT05648227Active Not Recruiting

Validation of an Artificial Intelligence Enabled Diagnostic Support Software (ArtiQ.Spiro) in Primary Care Spirometry Datasets - a Retrospective Analysis

Role: collaborator

NCT04909385Completed

TB PCR in BAL and EBUS-TBNA

Role: collaborator

NCT04375501Completed

A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic

Role: collaborator

NCT02261350Phase 3Terminated

Post-hospitalisation Nutritional Support and Gait Speed in COPD

Role: collaborator

NCT01507415Completed

Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?

Role: collaborator

All 6 trials loaded